Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shijiazhuang Lerentang Pharmaceutical
Shijiazhuang, Hebei Province, Chinalerentang.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
LRT is a profitable pharmaceutical company specializing in modernized Chinese traditional medicines with a strong focus on pain management products. The company has 127 SFDA-approved products in its portfolio[2]. Its flagship product, Zhong Tong An Capsules, is an effective pain medicine that accounted for approximately 50% of LRT's total revenue in 2007[2].
- Therapeutic areas
- HematologyImmunologyOtherCardiovascularNeurologyInfectious DiseasesGastroenterology
- Modalities
- Small molecule
- Industry
- Pharma
02
Partnerships
China Aoxing Pharmaceutical Company, Inc. (acquirer)
Beyond the preview
Go deeper on Shijiazhuang Lerentang Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shijiazhuang Lerentang Pharmaceutical.